DOSE Therapeutics, Inc. — Form D/A

DOSE Therapeutics, Inc. of DALLAS, TX, a company, filed a Form D amendment with the SEC on 2022-05-13. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2022-05-13
Form: D/A
Accession: 0001927425-22-000003
Industry: Biotechnology
Exemptions: 06b
Total offering: $10.0M
Amount sold: $10.0M
Investors: 20
Date of first sale: 2022-04-30
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-445465

Issuer

Name: DOSE Therapeutics, Inc.
CIK: 0001927425
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2021
Address: 3060 PEGASUS PARK, DALLAS, TX, 75247
Phone: 682-428-0043

Officers, directors & promoters (8)

Name	Role	Location
Blair Lapointe	Director	Dallas, TX
Steven L Mcknight	Director	Dallas, TX
John Fulton Murray	Director	Dallas, TX
Deepak Fulton Nijhawan	Director	Dallas, TX
McHenry T Tichenor	Director	Dallas, TX
Michael Bakes	Executive Officer	Dallas, TX
John Fulton Murray	Executive Officer	Dallas, TX
Michael Bakes	Director	Dallas, TX

Other filings by this issuer (1)

Filed	Form	Offering	Sold
2022-05-12	D	$10.0M	$10.0M

More